Indinavir

123 interactions 10 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Dihydroergotamine Injection Finerenone Ivabradine Colchicine Lovastatin Lurasidone
14 Contraindicated 85 Major 24 Moderate
All (123) Contraindicated (14) Major (85) Moderate (24)

Moderate

Indinavir Trospium / Xanomeline Cobenfy Explained Increased oral sensitive CYP3A4 substrate exposure and an increased risk on severity and frequency of sensitive CYP3A4 substrate-r... Details Indinavir Abemaciclib Verzenio Explained Increased abemaciclib plasma concentration Details Indinavir Amlodipine Amvaz® Increased plasma concentrations of calcium channel blockers Details Indinavir Ascorbic Acid (Vitamin C) C-500® Chewable Tablet Decreased indinavir plasma concentrations Details Indinavir Canagliflozin Invokana Worsening glycemic control Details Indinavir Didanosine Videx® Decreased bioavailability and therapeutic efficacy of indinavir Details Indinavir Dofetilide Tikosyn Increased dofetilide exposure Details Indinavir Felodipine Plendil® Increased plasma concentrations of calcium channel blockers Details Indinavir Guanfacine Intuniv Increased guanfacine exposure Details Indinavir Hydrocortisone Ala-Cort Increased hydrocortisone exposure and an increased risk of hydrocortisone-related adverse reactions Details Indinavir Hydrocortisone Injection A-Hydrocort® Increased hydrocortisone exposure and an increased risk of hydrocortisone-related adverse reactions Details Indinavir Isradipine DynaCirc® Increased plasma concentrations of calcium channel blockers Details Indinavir Levodopa Oral Inhalation Inbrija Enhanced levodopa effects manifested as severe dyskinesias Details Indinavir Linagliptin Tradjenta Worsening glycemic control Details Indinavir Mometasone Asmanex Increased mometasone plasma concentrations Details Indinavir Mometasone Nasal Spray Nasonex Increased mometasone plasma concentrations Details Indinavir Mometasone Oral Inhalation Asmanex Increased mometasone plasma concentrations Details Indinavir Mometasone Topical Elocon® Increased mometasone plasma concentrations Details Indinavir Nateglinide Starlix® Worsening glycemic control Details Indinavir Nevirapine Viramune Reduced indinavir exposure Details Indinavir Nicardipine Cardene Increased plasma concentrations of calcium channel blockers Details Indinavir Nifedipine Adalat® Increased plasma concentrations of calcium channel blockers Details Indinavir Nisoldipine Sular Increased plasma concentrations of calcium channel blockers Details Indinavir Paricalcitol Zemplar Increased plasma concentrations of paricalcitol Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.